SCHEMBL29559397

SCHEMBL29559397

Cc1cc2c(C(F)(F)F)ccc(CO)c2o1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP1B1 Q16678 1/20 0.41
ALDH1A1 P00352 3/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
KIF11 P52732 1/20 0.33
ACE2 Q9BYF1 1/20 0.32
NR1H2 P55055 2/20 0.31
NR1H3 Q13133 2/20 0.31
IDO1 P14902 2/20 0.31
RARA P10276 1/20 0.30
RARB P10826 1/20 0.30
RARG P13631 1/20 0.30
CSNK2A2 P19784 1/20 0.30
CSNK2B P67870 1/20 0.30
CSNK2A1 P68400 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24947176 1.00 CYP1A1 (0.41) CYP1A1CYP1A2CYP1B1ALDH1A1HPGD
SCHEMBL29558872 0.76 CYP1A2 (0.44) CYP1A1CYP1A2CYP1B1ALDH1A1HPGD
SCHEMBL30200448 0.76 ALDH1A1 (0.36) CYP1A2ALDH1A1HPGDHSD17B10
SCHEMBL24947178 0.76 CYP1A2 (0.44) CYP1A1CYP1A2CYP1B1ALDH1A1HPGD
SCHEMBL24947179 0.76 ALDH1A1 (0.36) CYP1A2ALDH1A1HPGDHSD17B10
SCHEMBL31384785 0.76 CYP1A2 (0.44) CYP1A1CYP1A2CYP1B1ALDH1A1HPGD
SCHEMBL29559045 0.72 NSD2 (0.34) ALDH1A1HPGDHSD17B10MAPT
SCHEMBL24947181 0.71 CFTR (0.43) CYP1A1CYP1A2CYP1B1ALDH1A1HPGD
SCHEMBL14099906 0.69 SMN1; SMN2 (0.43) KIF11NR1H2NR1H3IDO1
SCHEMBL2635958 0.68 CYP1A1 (0.43) CYP1A1CYP1A2CYP1B1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113480534-B Benzimidazole or azabenzimidazole-6-carboxylic acid compounds and application thereof 广州必贝特医药股份有限公司 2022-05-13 CN disclosed